CEPI and Oxford Vaccine Group in UK and Brazil partner to evaluate fractional COVID-19 booster vaccines

New global vaccine trial launched to evaluate fractional COVID-19 booster shots

CEPI opens Call to evaluate fractional COVID-19 booster and third shots as part of efforts to stretch global vaccine supply

CEPI partner INOVIO launches Lassa vaccine Phase I trial in West Africa

CEPI partner Inovio Advances Lassa Fever Candidate Vaccine Into a Clinical Trial